A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MMP

Search Conditions:
Search Keyword : MMP
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: MMP
Appearance Frequency: 17214 time(s)
Long forms: 308

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
matrix metalloproteinase
(12329 times)
Neoplasms
(1672 times)
TIMP (1158 times)
IL (936 times)
ECM (682 times)
1990 The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
mitochondrial membrane potential
(3788 times)
Pharmacology
(455 times)
ROS (1872 times)
MDA (222 times)
SOD (209 times)
1992 Involvement of intracellular Ca2+ and K+ in dissipation of the mitochondrial membrane potential and cell death induced by extracellular ATP in hepatocytes.
mucous membrane pemphigoid
(260 times)
Dermatology
(91 times)
BP (31 times)
BMZ (23 times)
PV (23 times)
1985 Localization of basement membrane components in mucous membrane pemphigoid.
monomethyl phthalate
(110 times)
Environmental Health
(79 times)
MEHP (57 times)
MEP (53 times)
MBP (43 times)
1991 Mutagenicity and metabolism of dimethyl phthalate and its binding to epidermal and hepatic macromolecules.
Medical Monitoring Project
(56 times)
Acquired Immunodeficiency Syndrome
(23 times)
ART (15 times)
HIV (15 times)
CI (7 times)
2007 Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.
matched molecular pair
(32 times)
Chemistry
(14 times)
SAR (7 times)
MMPA (3 times)
QSAR (3 times)
2010 Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.
membrane potential
(21 times)
Neurology
(4 times)
ROS (7 times)
ER (3 times)
mPTP (2 times)
1996 Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level.
methadone maintenance program
(21 times)
Medicine
(6 times)
AMP (2 times)
DFP (2 times)
HIV (2 times)
1989 [Prevalence of buprenorphine use by heroin addicts undergoing treatment].
microsatellite mutator phenotype
(18 times)
Neoplasms
(8 times)
MMR (3 times)
AP-PCR (2 times)
MSI (2 times)
1995 The microsatellite mutator phenotype of colon cancer cells is often recessive.
10  magnetic microparticle
(14 times)
Biotechnology
(3 times)
BCA (5 times)
BTV (2 times)
GNP (2 times)
2006 Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles.
11  major membrane protein
(14 times)
Allergy and Immunology
(5 times)
BCG (5 times)
DC (4 times)
HSP (4 times)
1990 The major native proteins of the leprosy bacillus.
12  masticatory myofascial pain
(13 times)
Dentistry
(6 times)
VAS (5 times)
PPT (4 times)
CV-angle (2 times)
2002 Masticatory myofascial pain: an explanatory model integrating clinical, epidemiological and basic science research.
13  matrix-degrading metalloproteinase
(13 times)
Vascular Diseases
(4 times)
TIMP (2 times)
UVB (2 times)
VSMC (2 times)
1997 Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines.
14  masticatory muscle pain
(12 times)
Dentistry
(10 times)
MPI (2 times)
TMD (2 times)
EMG (1 time)
1998 Psychological and physiological parameters of masticatory muscle pain.
15  methadone maintenance patients
(11 times)
Substance-Related Disorders
(8 times)
BMP (2 times)
WCST (2 times)
ADHD (1 time)
1995 Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients.
16  Mini-Mental Parkinson
(11 times)
Neurology
(4 times)
MMSE (7 times)
PD (4 times)
ACE-R (2 times)
2010 Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
17  2-methoxy-4-methylphenol
(8 times)
Neoplasms
(3 times)
HDO (3 times)
BPO (2 times)
HSG (2 times)
2004 Kinetic radical scavenging activity and cytotoxicity of 2-methoxy- and 2-t-butyl-substituted phenols and their dimers.
18  mean melting point
(8 times)
Endocrinology
(3 times)
FA (3 times)
PL (3 times)
DBI (2 times)
1991 Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation.
19  minimum miscibility pressure
(8 times)
Chemistry Techniques, Analytical
(2 times)
CO2-EOR (1 time)
FCM (1 time)
HPHT (1 time)
2005 Determination of gas-oil miscibility conditions by interfacial tension measurements.
20  mitochondrial myopathy
(8 times)
Cardiology
(4 times)
BMD (4 times)
CI (3 times)
MD (3 times)
1996 [Heart muscle involvement in myopathies].
21  maximal mean power
(7 times)
Sports Medicine
(5 times)
AT (1 time)
BCM (1 time)
CP (1 time)
2005 Power output during women's World Cup road cycle racing.
22  maximal mean power output
(7 times)
Sports Medicine
(5 times)
CP (2 times)
MT (1 time)
PCSpoints (1 time)
2015 Impact of Altitude on Power Output during Cycling Stage Racing.
23  mean maximal power
(7 times)
Sports Medicine
(7 times)
CP (2 times)
PT (2 times)
WT (2 times)
2020 Training Characteristics and Power Profile of Professional U23 Cyclists throughout a Competitive Season.
24  medication management program
(7 times)
Health Services Research
(2 times)
ARMIN (1 time)
CI (1 time)
CPs (1 time)
2015 Pharmacist-led medication management program within a patient-centered medical home.
25  membrane mitochondrial potential
(7 times)
Pediatrics
(1 time)
ROS (3 times)
LDHA (2 times)
A. muricata (1 time)
2009 Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis.
26  modified Mallampati grade
(7 times)
Otolaryngology
(7 times)
BMI (6 times)
AHI (5 times)
OSA (3 times)
1999 Clinical predictors of obstructive sleep apnea.
27  multichannel matching pursuit
(7 times)
Neurology
(4 times)
EEG (2 times)
ICA (2 times)
SVM (2 times)
2009 Inverse modeling on decomposed electroencephalographic data: a way forward?
28  Marine Mammal Program
(6 times)
Veterinary Medicine
(4 times)
EBC (1 time)
GGT (1 time)
2008 Trace and non-trace elements in blood cells of bottlenose dolphins (Tursiops truncatus): variations with values from liver function indicators.
29  medium molecular peptides
(6 times)
Urology
(2 times)
EI (2 times)
AOMP (1 time)
ATFE (1 time)
1991 [Blood levels of medium molecular weight peptides and lipid peroxidation activity in the differential diagnosis of diffuse toxic goiter].
30  metabolites, monomethyl phthalate
(6 times)
Environmental Health
(3 times)
MEP (5 times)
MEHP (4 times)
mBP (3 times)
2003 Improved quantitative detection of 11 urinary phthalate metabolites in humans using liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry.
31  modified Mallampati
(6 times)
Anesthesiology
(4 times)
BMI (2 times)
AASI (1 time)
CL (1 time)
2006 Craniocervical extension improves the specificity and predictive value of the Mallampati airway evaluation.
32  modulate metalloproteinase
(6 times)
Physiology
(2 times)
AD (1 time)
Ang (1 time)
Ang II (1 time)
2003 Regulation of trophoblastic gelatinases by proto-oncogenes.
33  Multiple Multipole Program
(6 times)
Biophysics
(3 times)
LSPR (2 times)
AFM (1 time)
FEM (1 time)
2005 Induced current density in the foetus of pregnant workers in high magnetic field environments.
34  methylmannose polysaccharide
(5 times)
Biochemistry
(3 times)
AMMP (1 time)
Ea (1 time)
FAs (1 time)
1977 Acetylated methylmannose polysaccharide of Streptomyces.
35  Mexican Migration Project
(5 times)
Social Medicine
(1 time)
MAFE (1 time)
MEPS (1 time)
PPACA (1 time)
2015 Mexican Immigrant Health: Health Insurance Coverage Implications.
36  middle mass peptides
(5 times)
Pharmacology
(2 times)
--- 1986 [Role of middle-molecule blood peptides in the development of cardiac depression in thermal burns].
37  minimum morbidity percentile
(5 times)
Environmental Health
(3 times)
OHCA (4 times)
DLNM (1 time)
MMT (1 time)
2016 Extreme temperature and out-of-hospital cardiac arrest in Japan: A nationwide, retrospective, observational study.
38  Mueller matrix polarimetry
(5 times)
Ophthalmology
(3 times)
CP (1 time)
LP (1 time)
MM (1 time)
2017 Use of Mueller matrix polarimetry and optical coherence tomography in the characterization of cervical collagen anisotropy.
39  multidimensional multiscale parser
(5 times)
Medical Informatics
(3 times)
HEVC (1 time)
PDS (1 time)
SbS (1 time)
2008 Universal image compression using multiscale recurrent patterns with adaptive probability model.
40  maximum mean pressure
(4 times)
Orthopedics
(3 times)
PP (3 times)
FTI (2 times)
BSI (1 time)
2005 The effect of terrain on foot pressures during walking.
41  metal matrix proteinase
(4 times)
Neoplasms
(2 times)
AQP3 (1 time)
ECM (1 time)
GMFB (1 time)
2013 Effect of Chinese herbs on immunoglobulin A nephropathy: a randomized controlled trial.
42  Microminipig
(4 times)
Pharmacology
(2 times)
CE (2 times)
HDL-C (2 times)
HFCD/SC (2 times)
2011 Microminipig, a non-rodent experimental animal optimized for life science research:novel atherosclerosis model induced by high fat and cholesterol diet.
43  mindfulness meditation practice
(4 times)
Psychophysiology
(1 time)
ANS (1 time)
MBCT (1 time)
MMD (1 time)
2014 Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.
44  modified multiple platform
(4 times)
Brain
(2 times)
PSD (2 times)
CPSD (1 time)
DA (1 time)
2004 Sleep deprivation induced by the modified multiple platform technique: quantification of sleep loss and recovery.
45  movement-monitoring potentials
(4 times)
Brain
(2 times)
MP (2 times)
MRCP (2 times)
MRPs (2 times)
2004 Relationship between plantar-flexor torque generation and the magnitude of the movement-related potentials.
46  malignant mesothelioma of the pleura
(3 times)
Medicine
(1 time)
Can-Qc (1 time)
1985 Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia.
47  matrix metalloproteinase-tissue inhibitor of metalloproteinase
(3 times)
Respiratory Tract Diseases
(1 time)
AIA (1 time)
COP (1 time)
OP (1 time)
1998 Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing.
48  medial midpatellar
(3 times)
Drug Delivery Systems
(1 time)
AM (2 times)
AL (1 time)
ALJL (1 time)
2006 Comparison of four different intra-articular injection sites in the knee: a cadaver study.
49  medical marijuana patients
(3 times)
Substance-Related Disorders
(3 times)
MM (2 times)
NPU (2 times)
2016 Marijuana practices and patterns of use among young adult medical marijuana patients and non-patient marijuana users.
50  medicine management plan
(3 times)
Geriatrics
(1 time)
DMS (1 time)
MRH (1 time)
RPT (1 time)
2022 Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge: a randomised controlled trial.
51  methylmercaptopurine
(3 times)
Pharmacology
(2 times)
6-MP (1 time)
AZA (1 time)
MP (1 time)
2002 Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes.
52  micro manipulating probe
(3 times)
Diagnostic Imaging
(2 times)
FEM (1 time)
2017 Controlled removal of micro/nanoscale particles in submillimeter-diameter area on a substrate.
53  micro-magnetic particle
(3 times)
Chemistry Techniques, Analytical
(2 times)
ABC (3 times)
BBC (2 times)
cyto c (2 times)
2013 An aptamer-based bio-barcode assay with isothermal recombinase polymerase amplification for cytochrome-c detection and anti-cancer drug screening.
54  modified Maquet procedure
(3 times)
Veterinary Medicine
(3 times)
CCLR (1 time)
PVF (1 time)
TPLO (1 time)
2016 The Modified Maquet Procedure (MMP) in Dogs: Technical Development and Initial Clinical Experience.
55  Montana Meth Project
(3 times)
Health Services
(2 times)
METH (1 time)
TEDS (1 time)
YRBS (1 time)
2008 Drugs, money, and graphic ads: a critical review of the Montana Meth Project.
56  Mucous membrane plasmacytosis
(3 times)
Otolaryngology
(2 times)
B-CLL (1 time)
2008 Mucous membrane plasmacytosis of the nose in a patient affected by B-cell chronic lymphocytic leukemia.
57  Multi-Muscle Pattern
(3 times)
Physiology
(3 times)
AFL (1 time)
BMI (1 time)
EMGs (1 time)
2008 Spherical classification of wavelet transformed EMG intensity patterns.
58  multicellular magnetotactic prokaryote
(3 times)
Microbiology
(2 times)
DMO (1 time)
2006 Magnetic optimization in a multicellular magnetotactic organism.
59  multiple multipole
(3 times)
Biomedical Engineering
(1 time)
AFM (1 time)
AMS (1 time)
FD (1 time)
1993 Multiple multipole method for simulating EM problems involving biological bodies.
60  myristoylated membrane protein
(3 times)
Allergy and Immunology
(1 time)
LCDV (2 times)
LCDV-PF (2 times)
MCP (2 times)
2014 Identification of lymphocystis disease virus from paradise fish Macropodus opercularis (LCDV-PF).
61  1-methoxy-5-methylphenazinium
(2 times)
Chemistry Techniques, Analytical
(2 times)
MP (1 time)
PCOP (1 time)
1999 Uricase-catalyzed oxidation of uric acid using an artificial electron acceptor and fabrication of amperometric uric acid sensors with use of a redox ladder polymer.
62  macrophage metalloprotease
(2 times)
Pulmonary Medicine
(1 time)
AAD (1 time)
BAL (1 time)
CAS (1 time)
2006 Involvement of MMP-12 and phosphodiesterase type 4 in cigarette smoke-induced inflammation in mice.
63  magnetotactic multicellular prokaryote
(2 times)
Biophysics
(1 time)
--- 2004 Observation of magnetoreceptive behavior in a multicellular magnetotactic prokaryote in higher than geomagnetic fields.
64  MammaPrint
(2 times)
Neoplasms
(1 time)
BCI (1 time)
CI (1 time)
EBC (1 time)
2019 Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score (RS) assay and other genomic assays for early breast cancer.
65  many-celled magnetotactic prokaryotes
(2 times)
Diagnostic Imaging
(1 time)
--- 2006 Flagellar apparatus of south-seeking many-celled magnetotactic prokaryotes.
66  maximum mean power
(2 times)
Sports Medicine
(2 times)
PP (1 time)
2010 The power profile predicts road cycling MMP.
67  mean maximal power output
(2 times)
Physiology
(2 times)
--- 2018 Sprinting for the Win: Distribution of Power Output in Women's Professional Cycling.
68  medication management pathway
(2 times)
Drug-Related Side Effects and Adverse Reactions
(1 time)
AF (1 time)
MEs (1 time)
2011 A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risks.
69  Medium-weight molecular peptide
(2 times)
Therapeutics
(2 times)
DTG (1 time)
LPO (1 time)
1991 [The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
70  membrane peptide
(2 times)
Allergy and Immunology
(1 time)
MAP (2 times)
APC (1 time)
CTL (1 time)
2019 A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
71  mesenteric malperfusion
(2 times)
Vascular Diseases
(2 times)
ABAD (1 time)
FL (1 time)
SMA (1 time)
2019 Mesenteric Malperfusion in Acute Aortic Dissection: Challenges and Frontiers.
72  metalloproteinase matrix
(2 times)
Jurisprudence
(1 time)
--- 2003 [Immunohistochemical findings in prolonged cerebral hypoxia].
73  metalloproteinases of matrix
(2 times)
Pulmonary Medicine
(1 time)
Lm (2 times)
MAC (2 times)
BMDM (1 time)
2017 A murine model of elastase- and cigarette smoke-induced emphysema.
74  metastatic melanoma patients
(2 times)
Neoplasms
(1 time)
BRAFi (1 time)
CI (1 time)
HR (1 time)
2015 The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600.
75  metastatic proteins metalloproteinase
(2 times)
Biochemistry
(1 time)
AGS (1 time)
AST (1 time)
ROS (1 time)
2009 Theaflavins retard human breast cancer cell migration by inhibiting NF-kappaB via p53-ROS cross-talk.
76  Million Mutation Project
(2 times)
Genetics
(2 times)
PhenoMIP (1 time)
WGS (1 time)
2016 Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies.
77  mitochondrial membrane-phospholipid
(2 times)
Digestive System Surgical Procedures
(1 time)
CoQ10 (1 time)
DCM (1 time)
omega-3 PUFAs (1 time)
1996 Effect of protection and repair of injury of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy.
78  Mixed methods psychometrics
(2 times)
Medicine
(1 time)
PRO (2 times)
CTT (1 time)
MG (1 time)
2021 Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
79  mixed muscle protein
(2 times)
Endocrinology
(1 time)
MHC (2 times)
GC-C-IRMS (1 time)
SDS-PAGE (1 time)
1997 Skeletal muscle myosin heavy chain synthesis in type 1 diabetes.
80  mizoribine 5'-monophosphate
(2 times)
Biochemistry
(2 times)
IMPDH (2 times)
TAD (1 time)
1995 Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding.
81  mobile measurement platform
(2 times)
Environmental Health
(2 times)
BC (1 time)
CO (1 time)
EMFAC (1 time)
2011 Emission factors for high-emitting vehicles based on on-road measurements of individual vehicle exhaust with a mobile measurement platform.
82  mono-methyl mono-phosphate ester
(2 times)
Chemistry
(2 times)
NBO (1 time)
NEDA (1 time)
QM/MM (1 time)
2007 Interactions between phosphate and water in solution: a natural bond orbital based analysis in a QM/MM framework.
83  mulberry marc purification
(2 times)
Nutritional Sciences
(1 time)
MJP (1 time)
2013 Antioxidant and anti-fatigue effects of anthocyanins of mulberry juice purification (MJP) and mulberry marc purification (MMP) from different varieties mulberry fruit in China.
84  Multifactor Measure of Performance
(2 times)
Cognitive Science
(1 time)
--- 2022 The Bar-On Model and Multifactor Measure of Human Performance: Validation and Application.
85  Mycophenolate mophetil
(2 times)
Ophthalmology
(1 time)
HSA (1 time)
MPA (1 time)
2012 Mycophenolate mofetil use in the treatment of noninfectious uveitis.
86  myosin/moesin phosphatase
(2 times)
Cell Biology
(1 time)
Inh-2 (1 time)
PP1 (1 time)
2000 Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading.
87  peroxynitrite-matrix metalloproteinase
(2 times)
Cardiology
(1 time)
CAD (1 time)
iNOS (1 time)
LVEF (1 time)
2010 Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
88  2-methoxy-2-methyl propanal
(1 time)
Biology
(1 time)
MMP-acid (1 time)
MMP-OH (1 time)
MTBE (1 time)
2009 Advanced oxidation and reduction process chemistry of methyl tert-butyl ether (MTBE) reaction intermediates in aqueous solution: 2-methoxy-2-methyl-propanal, 2-methoxy-2-methyl-propanol, and 2-methoxy-2-methyl-propanoic acid.
89  2-methoxy-2-methyl propionaldehyde
(1 time)
Environmental Health
(1 time)
AC (1 time)
AOP (1 time)
FA (1 time)
2001 MTBE oxidation by conventional ozonation and the combination ozone/hydrogen peroxide: efficiency of the processes and bromate formation.
90  2-methoxy-6-methylpyridine
(1 time)
Medicine
(1 time)
MTBE (1 time)
2019 Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine.
91  3-mercaptomethylpropionate
(1 time)
Chemistry
(1 time)
MNIC (1 time)
2014 Transformation of a mononitrosyl iron complex to a [2Fe-2S] cluster by a cysteine analogue.
92  3-methyl-4-(methylthio)phenol
(1 time)
Environmental Health
(1 time)
hERalpha (1 time)
HPLC (1 time)
MMS (1 time)
2009 A novel estrogenic compound transformed from fenthion under UV-A irradiation.
93  3-O-methyl-D-mannose-containing polysaccharide
(1 time)
Biochemistry
(1 time)
SD-MMP (1 time)
1977 Heterogeneity and refined structtures of 3-O-methyl-D-mannose polysaccharides from Mycobacterium smegmatis.
94  70-Major Membrane Protein
(1 time)
Pulmonary Medicine
(1 time)
HSP (1 time)
Mtb (1 time)
2021 Production of antibiotic resistance gene-free urease-deficient recombinant BCG that secretes antigenic protein applicable for practical use in tuberculosis vaccination.
95  actin-collagen-matrix metalloproteinases
(1 time)
Medicine
(1 time)
NHP (1 time)
2011 Improved xenobiotic metabolism and reduced susceptibility to cancer in gluten-sensitive macaques upon introduction of a gluten-free diet.
96  c-Myc, p53, Bax, Bcl-2, metalloproteinase
(1 time)
Medicine
(1 time)
MDM2 (1 time)
VEGF (1 time)
2016 [Effect and Regulatory Mechanism of Clock Gene Per1 on Biological Behaviors of Human Oral Squamous Carcinoma Cell].
97  Epac1-to-matrix metalloprotease
(1 time)
Neurology
(1 time)
Epac1 (1 time)
2013 Role of HIF-1alpha-activated Epac1 on HSC-mediated neuroplasticity in stroke model.
98  ERalpha-CD147-matrix metalloproteinase
(1 time)
Biology
(1 time)
CAFs (1 time)
CM (1 time)
ERalpha (1 time)
2022 Estrogen-responsive cancer-associated fibroblasts promote invasive property of gastric cancer in a paracrine manner via CD147 production.
99  Fe3O4-magainins I nanocomposites
(1 time)
Chemistry
(1 time)
PIP (1 time)
2020 Sandwich immunoassay based on antimicrobial peptide-mediated nanocomposite pair for determination of Escherichia coli O157:H7 using personal glucose meter as readout.
100  lysoPC-mediated proliferation could occur by stimulating metalloproteinase
(1 time)
Pharmacology
(1 time)
lysoPC (1 time)
ox-LDL (1 time)
SMC (1 time)
2002 Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix.